FDA Inspection 848983 — Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc — FEI 1000514603

The FDA completed an inspection of Regeneron Pharmaceuticals Inc on May 24, 2013 in Rensselaer, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rensselaer, NY (United States)

Citations

IDCFRDescription
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified